{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:56:52Z","timestamp":1761663412004},"reference-count":96,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Masters in Translational Oncology program (TCD) for Leah Quinn"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.lungcan.2015.11.002","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T20:18:37Z","timestamp":1447186717000},"page":"417-426","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Non-coding RNA repertoires in malignant pleural mesothelioma"],"prefix":"10.1016","volume":"90","clinical-trial-number":[{"clinical-trial-number":"nct02369198","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Leah","family":"Quinn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen P.","family":"Finn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinead","family":"Cuffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven G.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2015.11.002_bib0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ctrv.2014.10.007","article-title":"Malignant pleural mesothelioma: new hope in the horizon with novel therapeutic strategies","volume":"41","author":"Remon","year":"2015","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0010","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group","volume":"137","author":"Husain","year":"2013","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0015","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/jcp.22724","article-title":"Malignant mesothelioma: facts, myths, and hypotheses","volume":"227","author":"Carbone","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ccm.2012.12.005","article-title":"Malignant pleural mesothelioma: update on treatment options with a focus on novel therapies","volume":"34","author":"Haas","year":"2013","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0025","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1158\/2159-8290.CD-13-0202","article-title":"ceRNA cross-talk in cancer: when ce-bling rivalries go awry","volume":"3","author":"Karreth","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0030","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature12986","article-title":"The multilayered complexity of ceRNA crosstalk and competition","volume":"505","author":"Tay","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0035","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4161\/rna.20481","article-title":"The hallmarks of cancer: a long non-coding RNA point of view","volume":"9","author":"Gutschner","year":"2012","journal-title":"RNA Biol."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0040","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/thoraxjnl-2014-206193","article-title":"Non-coding RNA as lung disease biomarkers","volume":"70","author":"Vencken","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0045","doi-asserted-by":"crossref","DOI":"10.1093\/bfgp\/elv022","article-title":"Advances in long noncoding RNAs: identification, structure prediction and function annotation","author":"Guo","year":"2015","journal-title":"Brief. Funct. Genom."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0050","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cell.2009.02.006","article-title":"Evolution and functions of long noncoding RNAs","volume":"136","author":"Ponting","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0055","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1479-5876-10-103","article-title":"Novel classes of non-coding RNAs and cancer","volume":"10","author":"Sana","year":"2012","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0060","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.molcel.2011.08.018","article-title":"Molecular mechanisms of long noncoding RNAs","volume":"43","author":"Wang","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0065","doi-asserted-by":"crossref","first-page":"8027","DOI":"10.18632\/oncotarget.2469","article-title":"Correlation of long non-coding RNA expression with metastasis, drug resistance and clinical outcome in cancer","volume":"5","author":"Malek","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0070","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.canlet.2015.02.035","article-title":"The emergence of long non-coding RNAs in the tumorigenesis of hepatocellular carcinoma","volume":"360","author":"Yang","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0075","first-page":"1","article-title":"HOTAIR an oncogenic long non-coding RNA in different cancers","volume":"12","author":"Hajjari","year":"2015","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0080","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nature08975","article-title":"Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis","volume":"464","author":"Gupta","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0085","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10549-013-2776-7","article-title":"Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer","volume":"142","author":"Sorensen","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0090","doi-asserted-by":"crossref","first-page":"8765","DOI":"10.1038\/srep08765","article-title":"Prognostic impact of HOTAIR expression is restricted to ER-negative breast cancers","volume":"5","author":"Gokmen-Polar","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10549-015-3431-2","article-title":"Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer","volume":"152","author":"Zhang","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0100","first-page":"44","article-title":"Clinical utility of prostate carcinoma molecular diagnostic tests","volume":"10","author":"Shappell","year":"2008","journal-title":"Rev. Urol."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0105","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1200\/JCO.2013.52.8505","article-title":"Can urinary PCA3 supplement PSA in the early detection of prostate cancer?","volume":"32","author":"Wei","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0110","doi-asserted-by":"crossref","first-page":"e70940","DOI":"10.1371\/journal.pone.0070940","article-title":"Long non coding RNAs (lncRNAs) are dysregulated in malignant pleural mesothelioma (MPM)","volume":"8","author":"Wright","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0115","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.molcel.2014.07.012","article-title":"The long noncoding RNAs NEAT1 and MALAT1 bind active chromatin sites","volume":"55","author":"West","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0120","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1091\/mbc.E13-09-0558","article-title":"NEAT1 long noncoding RNA regulates transcription via protein sequestration within subnuclear bodies","volume":"25","author":"Hirose","year":"2014","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0125","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2014.01.009","article-title":"Long noncoding RNA NEAT1-dependent SFPQ relocation from promoter region to paraspeckle mediates IL8 expression upon immune stimuli","volume":"53","author":"Imamura","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0130","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0b013e3181da7687","article-title":"PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma","volume":"34","author":"Laury","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s13277-014-2818-8","article-title":"Small nucleolar RNAs functioning and potential roles in cancer","volume":"36","author":"Thorenoor","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0140","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1002\/j.1460-2075.1986.tb04578.x","article-title":"Chromosome 8 breakpoint far 3\u2032 of the c-myc oncogene in a Burkitt\u2019s lymphoma 2;8 variant translocation is equivalent to the murine pvt-1 locus","volume":"5","author":"Graham","year":"1986","journal-title":"EMBO J."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0145","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/nature13311","article-title":"PVT1 dependence in cancer with MYC copy-number increase","volume":"512","author":"Tseng","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0150","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/JTO.0b013e3181951ce8","article-title":"In arrayed ranks: array technology in the study of mesothelioma","volume":"4","author":"Gray","year":"2009","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0155","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/JTO.0000000000000202","article-title":"Frequent coamplification and cooperation between C-MYC and PVT1 oncogenes promote malignant pleural mesothelioma","volume":"9","author":"Riquelme","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0160","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/jclinpath-2011-200208","article-title":"Genomic gains and losses in malignant mesothelioma demonstrated by FISH analysis of paraffin-embedded tissues","volume":"65","author":"Takeda","year":"2012","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0165","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1349-7006.2006.00386.x","article-title":"Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32","volume":"98","author":"Taniguchi","year":"2007","journal-title":"Cancer Sci."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0170","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0092-8674(88)91065-3","article-title":"Genes specifically expressed at growth arrest of mammalian cells","volume":"54","author":"Schneider","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0175","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/cdd.2013.110","article-title":"Negative regulation of lncRNA GAS5 by miR-21","volume":"20","author":"Zhang","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0180","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1476-4598-13-119","article-title":"GAS5 long non-coding RNA in malignant pleural mesothelioma","volume":"13","author":"Renganathan","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0185","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12032-014-0024-6","article-title":"Podoplanin a novel regulator of tumor invasion and metastasis","volume":"31","author":"Dang","year":"2014","journal-title":"Med. Oncol."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0190","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/gcc.20808","article-title":"MiR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma","volume":"49","author":"Cortez","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0195","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2015.05.001","article-title":"An overview of microRNAs","volume":"87","author":"Hammond","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0200","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0205","doi-asserted-by":"crossref","first-page":"re3","DOI":"10.1126\/scisignal.2005825","article-title":"Dysregulation of microRNA biogenesis and gene silencing in cancer","volume":"8","author":"Hata","year":"2015","journal-title":"Sci. Signal"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0210","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3322\/caac.21244","article-title":"MicroRNAome genome: a treasure for cancer diagnosis and therapy","volume":"64","author":"Berindan-Neagoe","year":"2014","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0215","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1128\/MCB.00683-13","article-title":"Emerging roles of competing endogenous RNAs in cancer: insights from the regulation of PTEN","volume":"33","author":"de Giorgio","year":"2013","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0220","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.cell.2011.09.032","article-title":"In vivo identification of tumor-suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma","volume":"147","author":"Karreth","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0225","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2011.09.029","article-title":"Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs","volume":"147","author":"Tay","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0230","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13045-015-0129-1","article-title":"Competing endogenous RNA networks: tying the essential knots for cancer biology and therapeutics","volume":"8","author":"Sanchez-Mejias","year":"2015","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0235","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ctrv.2015.05.001","article-title":"The established and future biomarkers of malignant pleural mesothelioma","volume":"41","author":"Panou","year":"2015","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0240","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s13665-015-0106-8","article-title":"Discovery of new biomarkers for malignant mesothelioma","volume":"4","author":"Creaney","year":"2015","journal-title":"Curr. Pulmonol. Rep."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0245","doi-asserted-by":"crossref","first-page":"e114483","DOI":"10.1371\/journal.pone.0114483","article-title":"Combination of MiR-103a-3p and mesothelin improves the biomarker performance of malignant mesothelioma diagnosis","volume":"9","author":"Weber","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0250","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/oem.2009.049205","article-title":"Polymorphisms in the putative micro-RNA-binding sites of mesothelin gene are associated with serum levels of mesothelin-related protein","volume":"67","author":"Cristaudo","year":"2010","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0255","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1097\/JTO.0000000000000322","article-title":"A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people","volume":"9","author":"Garritano","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0260","first-page":"740","article-title":"Identification of circulating miRNA profiles that distinguish malignant pleural mesothelioma from lung adenocarcinoma","volume":"13","author":"Gayosso-Gomez","year":"2014","journal-title":"EXCLI J."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0265","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.clinbiochem.2012.02.009","article-title":"Clinical significance of circulating miR-126 quantification in malignant mesothelioma patients","volume":"45","author":"Tomasetti","year":"2012","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0270","doi-asserted-by":"crossref","first-page":"e30221","DOI":"10.1371\/journal.pone.0030221","article-title":"Identification of miRNA-103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma\u2014a pilot study","volume":"7","author":"Weber","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0275","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jmoldx.2014.03.002","article-title":"Diagnostic potential of miR-126, miR-143, miR-145, and miR-652 in malignant pleural mesothelioma","volume":"16","author":"Andersen","year":"2014","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0280","doi-asserted-by":"crossref","first-page":"e0135331","DOI":"10.1371\/journal.pone.0135331","article-title":"Two different serum miRNA signatures correlate with the clinical outcome and histological subtype in pleural malignant mesothelioma patients","volume":"10","author":"Lamberti","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0285","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/gcc.20669","article-title":"CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma\u2014a miRNA microarray analysis","volume":"48","author":"Guled","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0290","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1002\/ijc.25285","article-title":"Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma","volume":"127","author":"Gee","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0295","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1165\/rcmb.2009-0060OC","article-title":"MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications","volume":"42","author":"Busacca","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0300","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1038\/onc.2010.643","article-title":"Onconase mediated NFKbeta downregulation in malignant pleural mesothelioma","volume":"30","author":"Goparaju","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0305","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.yexmp.2014.09.016","article-title":"Analysis of microRNA expression signatures in malignant pleural mesothelioma, pleural inflammation, and atypical mesothelial hyperplasia reveals common predictive tumorigenesis-related targets","volume":"97","author":"Ramirez-Salazar","year":"2014","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0310","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1038\/onc.2013.476","article-title":"Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma","volume":"33","author":"Cioce","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0315","doi-asserted-by":"crossref","first-page":"635748","DOI":"10.1155\/2015\/635748","article-title":"MicroRNA and mRNA features of malignant pleural mesothelioma and benign asbestos-related pleural effusion","volume":"2015","author":"Ak","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0320","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.molonc.2014.11.007","article-title":"MiR-score a novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma","volume":"9","author":"Kirschner","year":"2015","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0325","doi-asserted-by":"crossref","first-page":"e24145","DOI":"10.1371\/journal.pone.0024145","article-title":"Haemolysis during sample preparation alters microRNA content of plasma","volume":"6","author":"Kirschner","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0330","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/JTO.0b013e3182572e83","article-title":"Increased circulating miR-625-3p: a potential biomarker for patients with malignant pleural mesothelioma","volume":"7","author":"Kirschner","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0335","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1093\/annonc\/mdt412","article-title":"Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma","volume":"24","author":"Reid","year":"2013","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0340","doi-asserted-by":"crossref","first-page":"22809","DOI":"10.1074\/jbc.M110.100354","article-title":"Pro-tumorigenic effects of miR-31 loss in mesothelioma","volume":"285","author":"Ivanov","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 1","key":"10.1016\/j.lungcan.2015.11.002_bib0345","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0169-5002(15)50003-2","article-title":"MicroRNA-31 expression mediates chemoresistance in malignant pleural mesothelioma","volume":"87","author":"Moody","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0350","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cancergen.2013.04.006","article-title":"Integrated high-resolution array CGH and SKY analysis of homozygous deletions and other genomic alterations present in malignant mesothelioma cell lines","volume":"206","author":"Klorin","year":"2013","journal-title":"Cancer Genet."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0355","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/ijc.23949","article-title":"Genomic events associated with progression of pleural malignant mesothelioma","volume":"124","author":"Ivanov","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0360","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1158\/0008-5472.CAN-09-3993","article-title":"hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma","volume":"70","author":"Pass","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0365","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1172\/JCI69735","article-title":"Aging and epigenetic drift: a vicious cycle","volume":"124","author":"Issa","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0370","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.lungcan.2013.09.017","article-title":"The degree of microRNA-34b\/c methylation in serum-circulating DNA is associated with malignant pleural mesothelioma","volume":"82","author":"Muraoka","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0375","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.3892\/or.2013.2351","article-title":"Downregulation of microRNA-34 induces cell proliferation and invasion of human mesothelial cells","volume":"29","author":"Tanaka","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0380","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1158\/1078-0432.CCR-10-3040","article-title":"Epigenetic silencing of microRNA-34b\/c plays an important role in the pathogenesis of malignant pleural mesothelioma","volume":"17","author":"Kubo","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0385","first-page":"4871","article-title":"MicroRNA miR-34b\/c enhances cellular radiosensitivity of malignant pleural mesothelioma cells","volume":"32","author":"Maki","year":"2012","journal-title":"Anticancer Res."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0390","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/2211536611201010034","article-title":"Function and regulation of let-7 family microRNAs","volume":"1","author":"Su","year":"2012","journal-title":"Microrna"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0395","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.tcb.2008.07.007","article-title":"The let-7 family of microRNAs","volume":"18","author":"Roush","year":"2008","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0400","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.0307323101","article-title":"Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers","volume":"101","author":"Calin","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0405","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ng.2007.30","article-title":"Widespread microRNA repression by Myc contributes to tumorigenesis","volume":"40","author":"Chang","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0410","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/cgt.2011.50","article-title":"EphrinA1 inhibits malignant mesothelioma tumor growth via let-7 microRNA-mediated repression of the RAS oncogene","volume":"18","author":"Khodayari","year":"2011","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0415","first-page":"4481","article-title":"Targeted delivery of let-7a microRNA encapsulated ephrin-A1 conjugated liposomal nanoparticles inhibit tumor growth in lung cancer","volume":"8","author":"Lee","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0420","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2353\/jmoldx.2010.090169","article-title":"A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma","volume":"12","author":"Benjamin","year":"2010","journal-title":"J. Mol. Diagn."},{"issue":"27","key":"10.1016\/j.lungcan.2015.11.002_bib0425","doi-asserted-by":"crossref","first-page":"23480","DOI":"10.18632\/oncotarget.4346","article-title":"MiR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma","volume":"6","author":"Williams","year":"2015","journal-title":"Oncotarget."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0430","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ncb1722","article-title":"The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1","volume":"10","author":"Gregory","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0435","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/modpathol.2011.144","article-title":"Epithelial-mesenchymal transition in malignant mesothelioma","volume":"25","author":"Fassina","year":"2012","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0440","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1158\/1541-7786.MCR-14-0442","article-title":"Loss of miR-223 and JNK signaling contribute to elevated stathmin in malignant pleural mesothelioma","volume":"13","author":"Birnie","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0445","first-page":"39","article-title":"Stathmin is overexpressed in malignant mesothelioma","volume":"27","author":"Kim","year":"2007","journal-title":"Anticancer Res."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0450","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1089\/ars.2013.5215","article-title":"MicroRNA-126 suppresses mesothelioma malignancy by targeting IRS1 and interfering with the mitochondrial function","volume":"21","author":"Tomasetti","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0455","first-page":"23","article-title":"Preclinical evaluation of microRNA-34b\/c delivery for malignant pleural mesothelioma","volume":"68","author":"Ueno","year":"2014","journal-title":"Acta Med. Okayama"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0460","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1164\/rccm.201503-0461LE","article-title":"A significant metabolic and radiological response after a novel targeted microRNA-based treatment approach in malignant pleural mesothelioma","volume":"191","author":"Kao","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lungcan.2015.11.002_bib0465","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1378\/chest.12-2770","article-title":"MiR-1 induces growth arrest and apoptosis in malignant mesothelioma","volume":"144","author":"Xu","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0470","doi-asserted-by":"crossref","first-page":"e18232","DOI":"10.1371\/journal.pone.0018232","article-title":"Association of miR-126 with soluble mesothelin-related peptides, a marker for malignant mesothelioma","volume":"6","author":"Santarelli","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0475","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1600-0463.2012.02891.x","article-title":"Are differentially expressed microRNAs useful in the diagnostics of malignant pleural mesothelioma?","volume":"120","author":"Andersen","year":"2012","journal-title":"APMIS"},{"key":"10.1016\/j.lungcan.2015.11.002_bib0480","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s12032-014-0303-2","article-title":"Upregulation of microRNA-31 associates with a poor prognosis of malignant pleural mesothelioma with sarcomatoid component","volume":"31","author":"Matsumoto","year":"2014","journal-title":"Med. Oncol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500215300994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500215300994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T05:47:28Z","timestamp":1599803248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500215300994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":96,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0169500215300994"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2015.11.002","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-coding RNA repertoires in malignant pleural mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2015.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}